Sugi Predict

Sugi Predict / Compounds / SCHEMBL6475474

SCHEMBL6475474

SCHEMBL6475474

CC(=O)c1ccc2nc([S+]([O-])Cc3ccccc3N(C)C)[nH]c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATP4A P20648 1/20 0.39
▸ ATP4B P51164 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CHEK2 O96017 7/20 0.36
▸ NPBWR1 P48145 1/20 0.35
▸ SIRT2 Q8IXJ6 1/20 0.35
▸ SIRT1 Q96EB6 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ PRMT5 O14744 1/20 0.35
▸ WDR77 Q9BQA1 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ FABP6 P51161 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6475466 0.92 ATP4A (0.39) ATP4AATP4BALDH1A1HPGDRAB9A
SCHEMBL9395701 0.89 LMNA (0.45) ATP4AATP4BALDH1A1HPGDRAB9A
SCHEMBL9396523 0.84 ATP4A (0.40) ATP4AATP4BALDH1A1POLBHPGD
SCHEMBL9678832 0.83 ATP4A (0.39) ATP4AATP4BALDH1A1HPGDRAB9A
SCHEMBL9395788 0.83 MAPT (0.40) ATP4AATP4BALDH1A1POLBHPGD
SCHEMBL9395895 0.83 ALDH1A1 (0.41) ATP4AATP4BALDH1A1HPGDRAB9A
SCHEMBL3689535 0.82 ATP4A (0.52) ATP4AATP4BALDH1A1POLBHPGD
SCHEMBL30637598 0.82 ATP4A (0.52) ATP4AATP4BALDH1A1POLBHPGD
SCHEMBL9677052 0.82 ALDH1A1 (0.41) ATP4AATP4BALDH1A1POLBHPGD
SCHEMBL10703138 0.81 ATP4A (0.37) ATP4AATP4BPRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010047038-A1 Method of using (H+/K+) ATPase inhibitors as antiviral agents MOORMAN ALAN E (US) 2001-11-29 — — US claimed
US-5945425-A ADENOSINE TRIPHOSPHASE INHIBITOR; DNA VIRICIDE G.D. SEARLE & CO. (US) 1999-08-31 — — US claimed
WO-1995029897-A1 METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS G.D. SEARLE & CO. (US) 1995-11-09 — — WO claimed
JP-62145069-A — — None — — JP disclosed
US-6906078-B2 Method of using (H+/K+) ATPase inhibitors as antiviral agents PHARMACIA CORPORATION (US) 2005-06-14 — — US disclosed
US-20010047038-A1 Method of using (H+/K+) ATPase inhibitors as antiviral agents MOORMAN ALAN E (US) 2001-11-29 — — US disclosed
US-5945425-A ADENOSINE TRIPHOSPHASE INHIBITOR; DNA VIRICIDE G.D. SEARLE & CO. (US) 1999-08-31 — — US disclosed
WO-1995029897-A1 METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS G.D. SEARLE & CO. (US) 1995-11-09 — — WO disclosed
JP-S62145069-A BENZIMIDAZOLE DERIVATIVE TAISHO PHARMACEUT CO LTD 1987-06-29 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010047038-A1 Method of using (H+/K+) ATPase inhibitors as antiviral agents ATP4A, ATP1A1, ATP1A4 ATP4A 1/4885ATP4B 8/4885ALDH1A1 2148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.